Close

Russia’s Sputnik V likely to be available for supply from January

Related stories

Pharmacy’s Impact on Reducing Medication Errors in Hospital Settings

Medication errors are a big problem in healthcare because...

How to Dispose of Pharmaceutical Waste

Proper pharmaceutical waste disposal is crucial for protecting our...

Semaglutide 101: What You Need to Know About This Game-Changing Medication

In the realm of modern medicine, breakthroughs are not...

Health Benefits of Pre-work Supplements

Whether you are a workout expert or just starting...

AI-Driven Pharmacovigilance with Real-Time Data Monitoring

Pharmacovigilance is about looking out for bad stuff from...

Russia’s Sputnik-V COVID-19 vaccine might become available for supply as early as next month, the country’s sovereign wealth fund RDIF’s top official told ThePrint.

According to Kirill Dmitriev, the Chief Operating Officer (COO) of RDIF, they are hoping for approval in January 2021, and are “ready to supply the vaccine to a wider population within the same timeframe”.

“As we understand, the country’s government is working on a special Covid-19 inoculation programme that would be using the processes, technology and network of the Universal Immunisation Programme (UIP) currently in place,” Dmitriev said while talking about the distribution process of the vaccine once it receives approval.

“Strengthening the cold chain systems and deploying trained personnel to ensure vaccine safety would be key to the inoculation process’s ultimate success. Another important thing would be to prioritise socio-demographic groups that would be among the first to gain access to the vaccine apart from healthcare professionals,” he added.

 

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Latest stories